Abbott Laboratories
ABT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $7 | $10 | $10 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $7 | $6 | $6 |
| Inventory | $6 | $7 | $6 | $5 |
| Other Curr. Assets | $3 | $2 | $3 | $2 |
| Total Curr. Assets | $24 | $23 | $25 | $24 |
| Property Plant & Equip (Net) | $12 | $11 | $10 | $10 |
| Goodwill | $23 | $24 | $23 | $23 |
| Intangibles | $7 | $9 | $10 | $13 |
| Long-Term Investments | $1 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $15 | $6 | $5 | $4 |
| Total NC Assets | $58 | $51 | $49 | $51 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $81 | $73 | $74 | $75 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $5 | $4 |
| Short-Term Debt | $2 | $1 | $2 | $1 |
| Tax Payable | $1 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $8 | $8 | $7 |
| Total Curr. Liab. | $14 | $14 | $15 | $13 |
| LT Debt | $14 | $15 | $15 | $18 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $2 | $2 |
| Other NC Liab. | $4 | $5 | $5 | $6 |
| Total NC Liab. | $19 | $21 | $22 | $26 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $34 | $34 | $38 | $39 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $25 | $25 | $25 | $24 |
| Retained Earnings | $47 | $38 | $35 | $32 |
| AOCI | -$8 | -$8 | -$8 | -$8 |
| Other Equity | -$17 | -$16 | -$15 | -$12 |
| Total Equity | $48 | $39 | $37 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $81 | $73 | $74 | $75 |
| Net Debt | $8 | $9 | $8 | $9 |